Saturday, August 18, 2018
Company News: Page (1) of 1 - 05/16/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Janssen to Present New Data in Urothelial, Hematologic and Prostate Cancers at ASCO 2018, Including Best of ASCO Selections
- Urothelial - Phase 2 data for investigational urothelial cancer therapy, erdafitinib- Hematologic - IMBRUVICA® Phase 3 data in first-line and relapsed/refractory Waldenström's macroglobulinemia;... By PR Newswire This article is no longer available,but here are some related topics.

Page: 1


About Video Based Tutorials - Contact Us - Advertise With Us - Privacy Guidelines